Long-term Effectiveness of Mailed Nicotine Replacement Therapy: A 5-year Follow-up
NCT03097445 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000
Last updated 2020-01-23
Summary
This study will perform a 5-year follow-up survey of participants in a randomized controlled trial that evaluated the effectiveness of providing 5 weeks of free NRT (in the form of the nicotine patch) by expedited postal mail without behavioural assistance to regular adult smokers recruited across Canada interested in receiving it (clinicaltrials.gov Identifier: NCT01429129).
Conditions
- Smoking Cessation
Interventions
- DRUG
-
Nicotine patch
mailed 5-week course of Habitrol® transdermal nicotine patches
Sponsors & Collaborators
-
Canadian Cancer Society (CCS)
collaborator OTHER -
Centre for Addiction and Mental Health
lead OTHER
Principal Investigators
-
John Cunningham, PhD · Centre for Addiction and Mental Health
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-06-04
- Primary Completion
- 2019-08-22
- Completion
- 2019-08-22
Countries
- Canada
Study Locations
More Related Trials
-
Self-directed Titrated Transdermal Nicotine Patch Versus Standard Treatment for Smoking Cessation
NCT01622998 ·Status: COMPLETED ·Phase: PHASE4
-
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
NCT00365508 ·Status: COMPLETED ·Phase: PHASE4
-
Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease
NCT00959972 ·Status: COMPLETED ·Phase: PHASE4
-
Smoking Cessation With Smokeless Tobacco, Nicotine Tablets and Nicotine Patches
NCT00313105 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Offering Nicotine Patches to All Households in a Municipality With High Smoking Rates
NCT04534231 ·Status: COMPLETED
-
Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine
NCT00710034 ·Status: COMPLETED ·Phase: PHASE2
-
Non-Nicotine Agents for Smoking Cessation
NCT00108537 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I Study: Stop Smoking Therapy for Ontario Patients (STOP)
NCT00356993 ·Status: COMPLETED ·Phase: NA
-
Treatment to Quit Smoking
NCT00018161 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Standard Versus Extended Nicotine Patch Therapy for Smoking Cessation
NCT00364156 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study of a New Nicotine Replacement Therapy
NCT00764439 ·Status: COMPLETED ·Phase: PHASE2
-
Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers
NCT01771627 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study Evaluating Nicotine Lozenges and Self Help
NCT00888459 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects
NCT06254001 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Non-invasive Brain Stimulation in Tobacco Use Disorder
NCT02776319 ·Status: UNKNOWN ·Phase: NA
-
Varenicline and Combined NRT for Smoking Cessation
NCT02271919 ·Status: COMPLETED ·Phase: PHASE4
-
Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II
NCT00734617 ·Status: COMPLETED ·Phase: PHASE3
-
An Open Label Study That Compares Varenicline to Transdermal Nicotine Patch for Smoking Cessation
NCT00143325 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Following Use of a Novel Nicotine Replacement Therapy
NCT00882375 ·Status: COMPLETED ·Phase: NA
-
Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers
NCT01048944 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy
NCT02355665 ·Status: COMPLETED ·Phase: PHASE3
-
Highdose Nicotine Patch Therapy for Smokeless Tobacco Use
NCT00939029 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Financial Incentives for Homeless Smokers: A Community-based RCT
NCT04445662 ·Status: COMPLETED ·Phase: NA
-
Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation
NCT01406223 ·Status: COMPLETED ·Phase: PHASE3
-
Supplemental Nicotine Administration for Smoking Cessation in Posttraumatic Stress Disorder (PTSD)
NCT01055886 ·Status: COMPLETED ·Phase: NA